Symmastia
Symmastia is a medical condition characterized by the confluence of the breast tissue of both breasts across the midline of the chest, creating what is commonly referred to as a "uniboob". This condition can be congenital, but it is most often caused by plastic surgery procedures, particularly breast augmentation.
Causes[edit]
Symmastia can be caused by a variety of factors. Congenital symmastia is a rare condition that is present from birth. It is thought to be caused by an abnormality in the development of the mammary glands and the connective tissue that separates them.
Acquired symmastia, on the other hand, is most commonly caused by plastic surgery procedures. This can occur when implants are placed too close together, or when the natural tissue is disrupted during surgery. Other causes can include weight gain, pregnancy, and hormonal changes.
Symptoms[edit]
The primary symptom of symmastia is the appearance of a single, continuous breast rather than two distinct breasts. This can cause discomfort and self-consciousness, as well as physical discomfort due to the pressure of the conjoined tissue.
Treatment[edit]
Treatment for symmastia typically involves surgery to correct the position of the implants or to reconstruct the natural tissue. This can be a complex procedure, as it requires careful planning and precision to ensure a natural-looking result. In some cases, non-surgical treatments such as compression garments or massage may be recommended to help reshape the tissue.
See also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
